Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-19

Clinical Trial Update: Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating the effectiveness of artesunate plus mefloquine for treatment of falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Mefloquine (Mefloquine)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Falciparum Malaria | Phase 2, Phase 3 | Status: COMPLETED